Matching Placebo (B): Clinical Trials

4 trials of Matching Placebo (B), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 enrolling by invitation, 1 recruiting. 2 Not applicable, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Enrolling by invitation 1
Phase 21Active not recruiting 1
Phase 31Recruiting 1

Follow Matching Placebo (B): new trials by email Literature Review of Matching Placebo (B) trials Research Report on Matching Placebo (B)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
AIM-WEIGHT: AI-Guided Microbiome-Targeted Nutritional Intervention for Weight Loss
AI-Guided Microbiome-Targeted Nutritional Supplement, Matching Placebo (B), Lifestyle counselling - Overweight (Without Type 2 Diabetes) With Weight-related Comorbidities, Overweight (BMI > 25)
Not applicableEnrolling by invitationVarol TUNALI802026-07-012026-09-29
The SELEQT-HF (SELEnium and CoQ10 NuTrition for Heart Failure) Study Will Evaluate the Effect of Adding Selenium/and coQ10 on Top of Standard HF Therapy in Patients With HF and Will do so Using a Pragmatic, Registry Based Randomized Controlled Trial in the Netherlands.
Selenium/CoQ10, Matching Placebo (B) - Heart Failure
Phase 3RecruitingNetherlands Heart Institute11002026-05-042026-05-19
Effect of PXS-4728A on Microglia Activation in Participants With Isolated Rapid Eye Movement Sleep Behaviour Disorder
PXS-4728 (A), Matching Placebo (B) - REM Sleep Behavior Disorder
Phase 2Active not recruitingSyntara402023-11-082026-06-02
Gdue Plus a Hypocaloric Mediterranean Diet in Adults With MASLD
Brown Algae and Chromium Picolinate Supplement, Matching Placebo (B) - Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Syndrome
Not applicableCompletedUniversity of Genova1122023-09-012026-08-13

Conditions studied

Fatty Liver (1)  ·  Heart Failure (1)  ·  Insulin Resistance (1)  ·  Metabolic Syndrome (1)  ·  Obesity (1)  ·  Overweight (1)  ·  REM Sleep Behavior Disorder (1)  ·  Weight Loss (1)

Sponsors

Netherlands Heart Institute (1)  ·  Syntara (1)  ·  University of Genova (1)  ·  Varol TUNALI (1)

Countries

Australia (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Jeroen Schaap, MD,PhD (1)  ·  Peter van der Meer, prof dr (1)